[Clinical evaluation of Rifampicin in pulmonary tuberculosis. 1. A preliminary study. The results of Rifampicin treatment for advanced pulmonary tuberculosis resistant to conventional antituberculous drugs].
D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008297:Male; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D012293:Rifampin